ARC Group has been invited to the 17th "Conference on Overseas Chinese Pioneering and Developing in China"

ARC Group has been invited to the 17th “Conference on Overseas Chinese Pioneering and Developing in China”

ARC Group Limited has been invited to the 17th“Conference on Overseas Chinese Pioneering and Developing in China”.

From July 7, 2017 to July 9, 2017, ARC Group has been honorably invited as a co-organizer to participate in the 17th Conference on Overseas Chinese Pioneering and Developing in China in Wuhan (the “Conference”).

ARC Group is looking forward to seeing you at this international investment session, the 17th “Conference on Overseas Chinese Pioneering and Developing in China”.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission